Table 5. Prevalence of Side Effects on Follow-up.

Symptom	Follow-up	EVLA No (%)	RFA No (%)	P value
Bruising	At 3 months	382 (70%)	268 (45%)	0.035
	At 6 months	208 (35%)	131 (22%)	0.05
	At 12 months	60 (10%)	54 (9%)	0.89
Pigmentation	At 3 months	137 (23%)	178 (30%)	0.04
	At 6 months	89 (15%)	89 (15%)	1
	At 12 months	36 (6%)	30(5%)	0.98
Dysesthesia	At 3 months	89 (15%)	119 (20%)	0.75
	At 6 months	48 (8%)	60 (10%)	0.89
	At 12 months	24 (4%)	30 (5%)	0.99
DVT	At 3 months	1 (0.18%)	2 (0.35%)	0.06
	At 6 months	0	0	1
	At 12 months	0	0	1

EVLA: endovenous laser ablation, RFA: radiofrequency ablation.